Fund Parallel Bioventures Mpm III Net Worth & Insider Trades

Fund Parallel Bioventures Mpm III Rigel Pharmaceuticals Inc

As of September 15, 2004

What is Fund Parallel Bioventures Mpm III's Net Worth?

The current estimated net worth of Rigel Pharmaceuticals Inc's Fund Parallel Bioventures Mpm III is estimated to be about $68.38M . Fund Parallel Bioventures Mpm III owns about 1,687,072 units of Rigel Pharmaceuticals Inc common stock. In the last 7 months at Rigel Pharmaceuticals Inc, Fund Parallel Bioventures Mpm III has sold an estimated value of $22.19M worth.

What is Fund Parallel Bioventures Mpm III's Past Insider Trading?

Fund Parallel Bioventures Mpm III's largest sale order was 316,302 units , worth over $6.3M on April 13, 2004. In total, Fund Parallel Bioventures Mpm III has made about 17 transactions over 7 months of their time at Rigel Pharmaceuticals Inc. Fund Parallel Bioventures Mpm III usually trades in June, with the busiest year in 2004. The most recent transaction was a sale order of 85,853 units , worth over $1.78M on September 2, 2004.

MPM BIOVENTURES III QP LP, MPM BIOVENTURES III LP, CO GMBH BIOVENTURES MPM III, FUND PARALLEL BIOVENTURES MPM III, MPM ASSET MANAGEMENT INVESTORS BVIII LLC, MPM BIOVENTURES III GP LP, MPM BIOVENTURES III LLC, NICHOLAS GALAKATOS, MICHAEL STEINMETZ, KURT WHEELER

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Fund Parallel Bioventures Mpm III's' Mailing Address?

  • Mailing address is The John Hancock Tower 200 Clarendon Street, 54th Floor Boston MA 02116 MA

What are Rigel Pharmaceuticals Inc's Past Insider Trades?

Rigel Pharmaceuticals Inc's most recent insider trade came on June 13, 2022 by Raul Rodriguez who bought 1,000,000 units worth $688.4K . In the last 18 years, insiders at Rigel Pharmaceuticals Inc have sold an estimated value of $206.52M and bought an estimated value of $21.84M worth of shares. Insider trading is most common in May, with the busiest year in 2004. The most active traders at the company are Dolly Vance, EVP Corp. Affairs,  Raul Rodriguez, CEO,  and Jean Deleage, Director .

RIGEL PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1